Neonatal Shock: Current Dilemmas and Future Research Avenues
Neonatal shock presents a complex clinical challenge and is one of the leading causes of mortality. Traditionally, neonatal shock is equated to hypotension, and therapeutics are often initiated based on low blood pressure (BP) values alone. This fails to address the underlying goal of optimizing the...
Saved in:
| Main Authors: | Vijay Kumar Krishnegowda, Arun Prasath, Viraraghavan Vadakkencherry Ramaswamy, Daniele Trevisanuto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/12/2/128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recognition and management of neonatal hemodynamic compromise
by: Tai-Wei Wu, et al.
Published: (2021-02-01) -
Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry
by: Matteo Pagnesi, et al.
Published: (2025-08-01) -
Corticosteroid use in neonatal hypotension: A survey of Canadian neonatologists
by: Ashraf Kharrat, et al.
Published: (2024-09-01) -
Time to vasopressor initiation and organ failure progression in early septic shock
by: Lauren Page Black, et al.
Published: (2020-06-01) -
Early initiated noradrenaline versus fluid therapy for hypotension and shock in the emergency department (VASOSHOCK): a protocol for a pragmatic, multi-center, superiority, randomized controlled trial
by: Lasse Paludan Bentsen, et al.
Published: (2025-04-01)